Compare · BYAH vs PG
BYAH vs PG
Side-by-side comparison of Park Ha Biological Technology Co. Ltd. (BYAH) and Procter & Gamble Company (PG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BYAH and PG operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- PG is the larger of the two at $339.23B, about 43056.2x BYAH ($7.9M).
- Over the past year, BYAH is down 98.7% and PG is down 2.7% - PG leads by 96.0 points.
- PG has hit the wire 32 times in the past 4 weeks while BYAH has been quiet.
- PG has more recent analyst coverage (25 ratings vs 0 for BYAH).
- Company
- Park Ha Biological Technology Co. Ltd.
- Procter & Gamble Company
- Price
- $1.92-21.95%
- $148.42+1.69%
- Market cap
- $7.9M
- $339.23B
- 1M return
- -5.57%
- +1.37%
- 1Y return
- -98.72%
- -2.70%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 0
- 32
- Recent ratings
- 0
- 25
Procter & Gamble Company
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments; and antiperspirants and deodorants, personal cleansing, and skin care products under the Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Latest BYAH
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- New insider Wang Li (Alya) claimed ownership of 187,500 units of Class A Ordinary Shares (SEC Form 3)
- CFO Zhu Xiaoyan was granted 112,500 units of Class A Ordinary Shares (SEC Form 4)
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form S-8 filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
Latest PG
- SEC Form 4 filed by Procter & Gamble Company
- SEC Form 4 filed by Procter & Gamble Company
- SEC Form 4 filed by Procter & Gamble Company
- Procter & Gamble upgraded by Evercore ISI with a new price target
- P&G to Webcast the Procter & Gamble 2026 Virtual Annual Meeting of Shareholders October 13
- SEC Form 4 filed by Procter & Gamble Company
- SEC Form 4 filed by Procter & Gamble Company
- SEC Form 4 filed by Procter & Gamble Company
- SEC Form 4 filed by Procter & Gamble Company
- Chf Rsch, Dev & Innov Officer Aguilar Moses Victor Javier was granted 5,732 shares, increasing direct ownership by 12% to 55,243 units (SEC Form 4)